Clinical Trials Study
Copyright ©The Author(s) 2025.
World J Psychiatry. Mar 19, 2025; 15(3): 99408
Published online Mar 19, 2025. doi: 10.5498/wjp.v15.i3.99408
Table 2 Demographic and clinical characteristics of the study cohorts, n (%)
Item
MDD (n = 75)
BD-D (n = 120)
HC (n = 100)
F/t
P value
Age (years)33.5 ± 12.131.0 ± 11.331.6 ± 6.01.4330.240
Gender1.5600.211
    Male18 (25.7)40 (33.3)23 (23.0)
    Female52 (74.3)80 (66.7)77 (77.0)
Years of education (years)13.7 ± 2.114.2 ± 2.615.9 ± 3.613.798< 0.001
Age at onset (years)30.2 ± 12.423.6 ± 8.73.919< 0.001
Disease duration (months)44.5 ± 59.987.4 ± 91.1-3.825< 0.001
Number of hospitalizations2.2 ± 1.66.0 ± 7.8-4.826< 0.001
HAMD scores23.8 ± 7.1a,b7.1 ± 8.3a,c0.4 ± 1.2b,c263.707< 0.001
HAMA scores14.6 ± 6.8a,b5.3 ± 7.3a,c0.3 ± 1.1b,c115.718< 0.001
PSQI scores11.5 ± 0.5a,b4.6 ± 0.33.9 ± 0.2b148.702< 0.001